Irinotecan, Gemcitabine, Chemotherapy for Biliary Tract Cancer
Status:
Completed
Trial end date:
2010-03-01
Target enrollment:
Participant gender:
Summary
The study hypothesis is that chemotherapy of irinotecan and gemcitabine will improve local
control of cancer and prolong survival in patients with inoperable biliary tract cancer.